pharma news

News

AbbVie's migraine drug cleared for migraine attacks on NHS

AbbVie's Aquipta can now be commissioned by the NHS in England and Wales as an acute treatment for migraine, after a NICE decision.

News

Cancer biotech Parabilis books record IPO, raising $670m

Parabilis has broken the IPO record set by Kailera in April, packing its coffers as it starts an ambitious trial programme for lead drug zolucatetide.

News

Stop sign with green fields in the background

Sanofi abandons phase 3 trial of neurology drug riliprubart

Sanofi's neurology pipeline has had a hole blown in it after a phase 3 trial of riliprubart in rare disease CIDP was stopped for futility.

News

Moderna Innovation and Technology Centre

Moderna jab on trial for cancer-causing syndrome

Patients with Lynch syndrome could have a potential treatment on the horizon, as a Moderna mRNA vaccine starts trials at Oxford University.

News

Jen Norton appointed market access leader at EVERSANA

EVERSANA has named Jen Norton as president of its recently formed Market Access & Value division.

News

Most doctors in UK think AI training is inadequate

A survey has shown that UK doctors think AI can help them save time and expand their capacity to care for patients, but training is lacking.

AbbVie's migraine drug cleared for migraine attacks on NHS

Cancer biotech Parabilis books record IPO, raising $670m

Sanofi abandons phase 3 trial of neurology drug riliprubart

Moderna jab on trial for cancer-causing syndrome

Jen Norton appointed market access leader at EVERSANA

Most doctors in UK think AI training is inadequate

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks